$133.93
-4.20-3.04%
最終更新: Oct 14, 4:00 PM
Benzinga
Benzinga
Benzinga
水曜日, 10 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Insulet (PODD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Insulet (PODD) は、8 5, 2026日にQ3の2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$829.9M - $844.03Mの範囲と予想しています。
以前のガイダンスと比較して、Insuletは売上高予測を以前の範囲である引き下げから$3.25B - $3.3Bに引き上げました。
Insuletは、36から11 3, 2022の間に8 5, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 16 times and lowered it 14 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.44 | $1.18 | $1.47 | $1.14 |
| Actual | $1.66 | $1.42 | $1.55 | $1.24 |
| Surprise | +15.3% | +20.3% | +5.44% | +8.77% |
| Revenue | ||||
| Estimate | $787.6M | $729.7M | $768.2M | $678.0M |
| Actual | $801.7M | $761.7M | $783.8M | $706.3M |
| Surprise | +1.79% | +4.38% | +2.03% | +4.18% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.59 | $1.85 | $1.62 | $1.83 |
| Revenue | ||||
| Consensus | $832.8M | $895.8M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $1.66 | $1.44 | 15.3 % |
| Q1 | May 6, 2026 | $1.42 | $1.18 | 20.3 % |
| Q4 | Feb 18, 2026 | $1.55 | $1.47 | 5.44 % |
| Q3 | Nov 6, 2025 | $1.24 | $1.14 | 8.77 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $801.70M | $787.63M | 1.79 % |
| Q1 | May 6, 2026 | $761.70M | $729.72M | 4.38 % |
| Q4 | Feb 18, 2026 | $783.80M | $768.17M | 2.03 % |
| Q3 | Nov 6, 2025 | $706.30M | $677.96M | 4.18 % |